Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


“Time & Extent” Botanical Candidates To Lead Off With Ginger, Valerian?

This article was originally published in The Tan Sheet

Executive Summary

Ginger and valerian are promising prospects for FDA determinations on OTC drug monograph eligibility under the "material time, material extent" final rule

You may also be interested in...

FDA “Material Time, Material Extent” Rule May Be Cloudy For Sunscreens

Interim marketing for OTC drugs or "conditions" in the U.S. subject to a final or new monograph is barred under FDA's final rule on "material time, material extent" criteria

OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs

Sponsors of OTC drugs with extensive foreign marketing experience need not provide detailed information from each country in requesting the drug or "condition" be considered for OTC monograph eligibility in the U.S., FDA says

Monograph Eligibility To Include U.S. Rx-Only Drugs With Foreign OTC Data

A drug marketed OTC in foreign countries but limited to Rx use in the U.S. could be considered for eligibility in the OTC monograph system under FDA's final rule on "material time, material extent" criteria, published in the Federal Register Jan. 23

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts